R&D_Changchun GeneScience Pharmaceutical Co., Ltd.

Home
About Us 
Established in 1996, Changchun GeneScience Pharmaceutical Co., Ltd. (hereinafter referred to as ‘‘GenSci’) is one of the holding subsidiaries of Changchun High-tech (SZSE 000661)
Company Profile

Contact Us
Product 
Pharmaceutical

Medical Apparatus
R&D 
Pipeline and Therapeutic Fields

Key R&D Progress
Global Marketing
CSR

Please Enter Keywords To Search For Content

Close

CN

Home
About Us 
- Company Profile
- Contact Us
Product 
- Pharmaceutical
- Medical Apparatus
R&D 
- Pipeline and Therapeutic Fields
- Key R&D Progress
Global Marketing
CSR

1

Home

/

R&D





R&D

GenSci is dedicated to serving patients wholeheartedly and to providing high-quality products.

GenSci is dedicated to serving patients wholeheartedly and to providing high-quality products.

Pipeline Field

At present, GenSci has more than 16 projects in the preclinical stage, and 8 projects are undergoing clinical stage. Therapeutic fields include growth and development, assisted reproduction, tumor, immune, antiviral and metabolic diseases, etc...

R&D Trends

GenSci059 was granted for clinical trial license by NMPA in September 2020 and Study May Proceed by US FDA in December 2020. It is deemed a milestone marked GenSci’s R&D project in conformity to international...